semaglutide trial adolescents obesity 2022 Frontiers | Case report: Long-term efficacy and safety of in the treatment of syndromic in Prader Willi syndrome Once-weekly semaglutide 7·2 mg in
Description
Lab Invest 102:6979
00226-8/asset/fd74d5b9-b94f-420a-ba3e-9f0baf1be2f1/main.assets/gr2_lrg.jpg)
Stress-related eating often compounds the problem by increasing calorie intake, particularly from comfort foods high in refined carbohydrates
What are your thoughts
(C) Glp-1r / islets also secreted insulin in response to high glucose, but no potentiation was observed with GLP-1, OXM, or EX-4 treatment
Patients who desire to lose more weight can repeat the program as often as needed
References: Clinical case notes and insights: Ongoing research and professional commentary: Emerging Frontiers: Duals, Triples, and Beyond Why add GIP or glucagon agonism
